The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants
Open accessAbstract
BACKGROUND: The generalizability of clinical trial results is questionable, because fewer than 5% of cancer patients participate. The authors examined the comparability of clinical trial participants and nonparticipants and the potential impact of differences. METHODS: A retrospective cohort of 19,340 cancer patients who were diagnosed between January 1990 and December 1997 was characterized by trial participation. The distributions of prognostically important factors among trial participants were compared with the distributions among nonparticipants and the population of patients diagnosed during the same period in the Surveillance, Epidemiology, and End Results population. The impact of these factors on survival was examined by using a Cox proportional hazards analysis. RESULTS: Trial participants were younger and had better performance status and fewer comorbid conditions compared with nonparticipants. However, participants were more likely to have locally advanced disease, positive lymph node status, poorly differentiated tumors, liver metastases, and multiple metastatic sites. The former factors were associated with significantly longer survival, whereas the later factors were associated with significantly shorter survival. CONCLUSIONS: The lack of comparability between trial participants and nonparticipants called into question the generalizability of clinical trial results. Although selective recruitment for clinical trials is justified, the authors encourage the use of population‐based trials of effectiveness in “all comers.” Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Large-scale randomized evidence: Large, simple trials and overviews of trials
Peto, R., Collins, R., & Gray, R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00150-o · Cited by 365
Cited by
Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S., & Johnston, J. (2015) · Trials · doi:10.1186/s13063-015-1023-4 · Cited by 878
Smith, A., Crouch, S., Lax, S., Li, J., Painter, D., Howell, D., Patmore, R., Jack, A., & Roman, E. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.94 · Cited by 424
The use of smartphones for health research
Dorsey, E. R., “Yvonne” Chan, Y.-F., McConnell, M. V., Shaw, S. Y., Trister, A. D., & Friend, S. H. (2017) · Academic Medicine · doi:10.1097/acm.0000000000001205 · Cited by 154
Indorewalla, K. K., O’Connor, M. K., Budson, A. E., Guess (DiTerlizzi), C., & Jackson, J. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201081 · Cited by 93
Harnessing Real-World Evidence to Advance Cancer Research
Tang, M., Pearson, S.-A., Simes, R. J., & Chua, B. H. (2023) · Current Oncology · doi:10.3390/curroncol30020143 · Cited by 88
Metadata
- Authors
- Elting, L. S., Cooksley, C., Bekele, B. N., Frumovitz, M., Avritscher, E. B. C., Sun, C., & Bodurka, D. C.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-05-18
- Volume
- 106
- Issue
- 11
- Pages
- 2452-2458
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2051859609
- Cited by
- 176
- References
- 2
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. https://app.cochat.ai/papers/10.1002/cncr.21907
- The paper
- Elting, L. S., Cooksley, C., Bekele, B. N., Frumovitz, M., Avritscher, E. B. C., Sun, C., & Bodurka, D. C. (2006). Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. Cancer. https://doi.org/10.1002/cncr.21907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.